| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16.1M | — | +17.4% |
| Cost of Revenue | $10.5M | — | +30.8% |
| Gross Profit | $5.6M | — | -1.4% |
| R&D Expense | $501K | — | -43.7% |
| SG&A Expense | $7.6M | — | +12.5% |
| Operating Income | -$2.8M | — | -23.0% |
| Pre-tax Income | -$20.3M | — | +28.8% |
| Income Tax | $266K | — | +120.9% |
| Net Income | -$20.6M | — | +28.5% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20.5M | +312.2% | +385.4% |
| Inventory | $7.4M | +12.9% | -33.1% |
| Current Assets | $42.7M | +47.2% | +47.1% |
| Total Assets | $60.3M | +26.2% | +29.2% |
| Current Liabilities | $18.0M | -24.6% | -27.9% |
| Long-term Debt | $12.8M | -5.6% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$892K | — | +25.8% |
| Capital Expenditures | $184K | — | -80.1% |
| Investing Cash Flow | -$253K | — | +74.9% |
| Financing Cash Flow | $17.3M | — | +624.8% |
| Free Cash Flow | -$1.1M | — | +49.4% |
| -31.8% |
| Total Liabilities | $31.2M | -20.0% | -35.2% |
| Stockholders' Equity | $29.1M | +233.7% | +1965.3% |